Research programme: BMP 7 analogue - Eyegene

Drug Profile

Research programme: BMP 7 analogue - Eyegene

Alternative Names: BMP-7 - Eyegene; EGS 001

Latest Information Update: 16 Jul 2016

Price : $50

At a glance

  • Originator EyeGene
  • Class
  • Mechanism of Action Epidermal growth factor inhibitors; Fibroblast growth factor inhibitors; Interleukin inhibitors; Prostaglandin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Corneal injuries; Scars

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Corneal injuries in South Korea (Ophthalmic, Drops)
  • 16 Jul 2016 No recent reports of development identified for preclinical development in Scars in South Korea (Topical, Ointment)
  • 01 Jan 2013 Preclinical trials in Corneal injuries in South Korea (Ophthalmic)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top